Terkko Navigator / -/ Feeds / " ( ( Tulehdukselliset suolistosairaudet )|( Tulehduksellinen suolistosairaus )|( Inflammat"

Lapsuudessa alkanut tulehduksellinen suolistosairaus saattaa liittyä syöpäriskiin

IJMS, Vol. 23, Pages 7093: Arabinoxylan and Pectin Metabolism in Crohn’s Disease Microbiota: An In Silico Study

Tulehduksellinen suolistosairaus lyhentää elinikää edelleen, mutta vähemmän kuin ennen

IJMS, Vol. 23, Pages 6966: Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response

Biomedicines, Vol. 10, Pages 1492: The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease

Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases

Nutrients, Vol. 14, Pages 2522: Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease

Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease

Microorganisms, Vol. 10, Pages 1273: Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease

Cancers, Vol. 14, Pages 2914: Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease

The role of PET imaging in inflammatory bowel diseases: state-of-the-art review

Näin tulehduksellinen suolistosairaus vaikuttaa elinikään

IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease.

IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease.

IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease.

Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition.

Suolistosairaudet lisääntyvät huippuvauhtia – nämä oireet kertovat sairastumisesta

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group.

“Inflammatory Bowel Disease—Not Just the Bowel’s Bane”: Peripheral Arterial and Venous Thrombosis in a Patient With Crohn Disease

Tulehduksellinen suolistosairaus lyhentää elinikää edelleen, mutta vähemmän kuin ennen

Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study

Tulehdukselliset suolistosairaudet voivat lisätä suusyövän riskiä

Tulehdukselliset suolistosairaudet voivat lisätä suusyövän riskiä

Tulehdukselliset suolistosairaudet voivat lisätä suusyövän riskiä

Tulehdukselliset suolistosairaudet voivat lisätä suusyövän riskiä

Tulehdukselliset suolistosairaudet voivat lisätä suusyövän riskiä

Tulehdukselliset suolistosairaudet voivat lisätä suusyövän riskiä

Tulehdukselliset suolistosairaudet voivat lisätä suusyövän riskiä

IJMS, Vol. 22, Pages 11155: Cytosolic Phospholipase A2 is Required for Fexofenadine′s Therapeutic Effects Against Inflammatory Bowel Disease in Mice

Inflammatory Bowel Disease in Patients with Congenital Chloride Diarrhoea

Inferring intestinal mucosal immune cell associated microbiome species and microbiota-derived metabolites in inflammatory bowel disease

Veterinary Sciences, Vol. 7, Pages 141: Neutrophil-to-Lymphocyte Ratio (NLR) in Canine Inflammatory Bowel Disease (IBD)

IJMS, Vol. 21, Pages 7893: MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer

Nutrients, Vol. 13, Pages 3143: Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside

Nanomaterials, Vol. 12, Pages 280: Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α−/− Transgenic Mouse Model Using Targeted Microbubbles

Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering

Cells, Vol. 10, Pages 3188: Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy

Antioxidants, Vol. 9, Pages 1081: Sigma-1 Receptor Engages an Anti-Inflammatory and Antioxidant Feedback Loop Mediated by Peroxiredoxin in Experimental Colitis

Evolving Care and Diagnostics in Inflammatory Bowel Diseases : Infliximab Therapy Optimization & Motility-based Crohn's Disease Detection

Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Inflammatory bowel disease in patients undergoing renal biopsies.

Inflammatory bowel disease in patients undergoing renal biopsies.

Inflammatory bowel disease in patients undergoing renal biopsies.